Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
Aoun, Bilal; Decramer, Stéphane; Vitkevic, Renata; Wannous, Hala; Bandin, Flavio; Azema, Christine; Callard, Patrice; Brocheriou, Isabelle; Ulinski, Tim.
; 28(3): 493-8, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23111894
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
Cyclosporin versus tacrolimus for liver transplanted patients.
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year observational results.
Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
[The effectiveness and safety of topical 0.1% tacrolimus after high-risk penetrating keratoplasty].
Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-year observational results.
Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
Management of tacrolimus-associated food allergy after liver transplantation.
Conversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key.